 | • レポートコード：QFJ1-4750 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、着床前診断（PGD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（染色体異常、性別選択、X連鎖性疾患、異数性、単一遺伝子障害、その他）、用途別市場規模（マタニティセンター＆不妊治療クリニック、病院、診断ラボ、サービスプロバイダー、研究所、学術機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・着床前診断（PGD）の市場動向 ・企業の競争状況、市場シェア ・着床前診断（PGD）の種類別市場規模と予測2016-2027（染色体異常、性別選択、X連鎖性疾患、異数性、単一遺伝子障害、その他） ・着床前診断（PGD）の用途別市場規模と予測2016-2027（マタニティセンター＆不妊治療クリニック、病院、診断ラボ、サービスプロバイダー、研究所、学術機関） ・着床前診断（PGD）の北米市場規模2016-2027（アメリカ、カナダ） ・着床前診断（PGD）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・着床前診断（PGD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・着床前診断（PGD）の中南米市場規模2016-2027（メキシコ、ブラジル） ・着床前診断（PGD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Illumina、Thermo Fisher、Agilent Technologies、PerkinElmer、Coopersurgical、Abbott Laboratories、Natera、Takara Bio、Oxford Gene Technology、Yikon Genomics、Progenesis、Beijing Genomics Institute、Invitae、Invicta Genetics、Combimatrix、Genea Limited、Bioarray、Quest Diagnostics） ・結論 |
Market Analysis and Insights: Global Preimplantation Genetic Diagnosis (PGD) Market
The global Preimplantation Genetic Diagnosis (PGD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preimplantation Genetic Diagnosis (PGD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preimplantation Genetic Diagnosis (PGD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preimplantation Genetic Diagnosis (PGD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preimplantation Genetic Diagnosis (PGD) market.
Global Preimplantation Genetic Diagnosis (PGD) Scope and Market Size
Preimplantation Genetic Diagnosis (PGD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetic Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chromosomal Abnormalities
Gender Selection
X-linked Diseases
Aneuploidy
Single Gene Disorders
Others
Segment by Application
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Illumina
Thermo Fisher
Agilent Technologies
PerkinElmer
Coopersurgical
Abbott Laboratories
Natera
Takara Bio
Oxford Gene Technology
Yikon Genomics
Progenesis
Beijing Genomics Institute
Invitae
Invicta Genetics
Combimatrix
Genea Limited
Bioarray
Quest Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chromosomal Abnormalities
1.2.3 Gender Selection
1.2.4 X-linked Diseases
1.2.5 Aneuploidy
1.2.6 Single Gene Disorders
1.2.7 Others
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Diagnosis (PGD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals, Diagnostic Labs, and Service Providers
1.3.4 Research Laboratories & Academic Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Perspective (2016-2027)
2.2 Preimplantation Genetic Diagnosis (PGD) Growth Trends by Regions
2.2.1 Preimplantation Genetic Diagnosis (PGD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preimplantation Genetic Diagnosis (PGD) Historic Market Share by Regions (2016-2021)
2.2.3 Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027)
2.3 Preimplantation Genetic Diagnosis (PGD) Industry Dynamic
2.3.1 Preimplantation Genetic Diagnosis (PGD) Market Trends
2.3.2 Preimplantation Genetic Diagnosis (PGD) Market Drivers
2.3.3 Preimplantation Genetic Diagnosis (PGD) Market Challenges
2.3.4 Preimplantation Genetic Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetic Diagnosis (PGD) Players by Revenue (2016-2021)
3.1.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2016-2021)
3.2 Global Preimplantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetic Diagnosis (PGD) Revenue
3.4 Global Preimplantation Genetic Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnosis (PGD) Revenue in 2020
3.5 Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetic Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetic Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetic Diagnosis (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Type (2016-2021)
4.2 Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2022-2027)
5 Preimplantation Genetic Diagnosis (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Application (2016-2021)
5.2 Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Preimplantation Genetic Diagnosis (PGD) Market Size (2016-2027)
6.2 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Type
6.2.1 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
6.2.2 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
6.2.3 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
6.3 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Application
6.3.1 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
6.3.2 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
6.3.3 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
6.4 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country
6.4.1 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
6.4.2 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Preimplantation Genetic Diagnosis (PGD) Market Size (2016-2027)
7.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type
7.2.1 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
7.2.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
7.2.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
7.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application
7.3.1 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
7.3.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
7.3.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
7.4 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country
7.4.1 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
7.4.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size (2016-2027)
8.2 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Type
8.2.1 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Application
8.3.1 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region
8.4.1 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size (2016-2027)
9.2 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Type
9.2.1 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
9.2.2 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
9.2.3 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
9.3 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Application
9.3.1 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
9.3.2 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
9.3.3 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
9.4 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country
9.4.1 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
9.4.2 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size (2016-2027)
10.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type
10.2.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application
10.3.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country
10.4.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Introduction
11.1.4 Illumina Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Introduction
11.2.4 Thermo Fisher Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.2.5 Thermo Fisher Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Introduction
11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Details
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Introduction
11.4.4 PerkinElmer Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.4.5 PerkinElmer Recent Development
11.5 Coopersurgical
11.5.1 Coopersurgical Company Details
11.5.2 Coopersurgical Business Overview
11.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Introduction
11.5.4 Coopersurgical Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.5.5 Coopersurgical Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Introduction
11.6.4 Abbott Laboratories Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.6.5 Abbott Laboratories Recent Development
11.7 Natera
11.7.1 Natera Company Details
11.7.2 Natera Business Overview
11.7.3 Natera Preimplantation Genetic Diagnosis (PGD) Introduction
11.7.4 Natera Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.7.5 Natera Recent Development
11.8 Takara Bio
11.8.1 Takara Bio Company Details
11.8.2 Takara Bio Business Overview
11.8.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Introduction
11.8.4 Takara Bio Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.8.5 Takara Bio Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Details
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Introduction
11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.9.5 Oxford Gene Technology Recent Development
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Details
11.10.2 Yikon Genomics Business Overview
11.10.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Introduction
11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.10.5 Yikon Genomics Recent Development
11.11 Progenesis
11.11.1 Progenesis Company Details
11.11.2 Progenesis Business Overview
11.11.3 Progenesis Preimplantation Genetic Diagnosis (PGD) Introduction
11.11.4 Progenesis Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.11.5 Progenesis Recent Development
11.12 Beijing Genomics Institute
11.12.1 Beijing Genomics Institute Company Details
11.12.2 Beijing Genomics Institute Business Overview
11.12.3 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Introduction
11.12.4 Beijing Genomics Institute Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.12.5 Beijing Genomics Institute Recent Development
11.13 Invitae
11.13.1 Invitae Company Details
11.13.2 Invitae Business Overview
11.13.3 Invitae Preimplantation Genetic Diagnosis (PGD) Introduction
11.13.4 Invitae Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.13.5 Invitae Recent Development
11.14 Invicta Genetics
11.14.1 Invicta Genetics Company Details
11.14.2 Invicta Genetics Business Overview
11.14.3 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Introduction
11.14.4 Invicta Genetics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.14.5 Invicta Genetics Recent Development
11.15 Combimatrix
11.15.1 Combimatrix Company Details
11.15.2 Combimatrix Business Overview
11.15.3 Combimatrix Preimplantation Genetic Diagnosis (PGD) Introduction
11.15.4 Combimatrix Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.15.5 Combimatrix Recent Development
11.16 Genea Limited
11.16.1 Genea Limited Company Details
11.16.2 Genea Limited Business Overview
11.16.3 Genea Limited Preimplantation Genetic Diagnosis (PGD) Introduction
11.16.4 Genea Limited Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.16.5 Genea Limited Recent Development
11.17 Bioarray
11.17.1 Bioarray Company Details
11.17.2 Bioarray Business Overview
11.17.3 Bioarray Preimplantation Genetic Diagnosis (PGD) Introduction
11.17.4 Bioarray Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.17.5 Bioarray Recent Development
11.18 Quest Diagnostics
11.18.1 Quest Diagnostics Company Details
11.18.2 Quest Diagnostics Business Overview
11.18.3 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Introduction
11.18.4 Quest Diagnostics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
11.18.5 Quest Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chromosomal Abnormalities
Table 3. Key Players of Gender Selection
Table 4. Key Players of X-linked Diseases
Table 5. Key Players of Aneuploidy
Table 6. Key Players of Single Gene Disorders
Table 7. Key Players of Others
Table 8. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Regions (2016-2021)
Table 12. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Regions (2022-2027)
Table 14. Preimplantation Genetic Diagnosis (PGD) Market Trends
Table 15. Preimplantation Genetic Diagnosis (PGD) Market Drivers
Table 16. Preimplantation Genetic Diagnosis (PGD) Market Challenges
Table 17. Preimplantation Genetic Diagnosis (PGD) Market Restraints
Table 18. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Players (2016-2021)
Table 20. Global Top Preimplantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnosis (PGD) as of 2020)
Table 21. Ranking of Global Top Preimplantation Genetic Diagnosis (PGD) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Preimplantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Preimplantation Genetic Diagnosis (PGD) Product Solution and Service
Table 25. Date of Enter into Preimplantation Genetic Diagnosis (PGD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
Table 29. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Preimplantation Genetic Diagnosis (PGD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2016-2021)
Table 33. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Illumina Company Details
Table 66. Illumina Business Overview
Table 67. Illumina Preimplantation Genetic Diagnosis (PGD) Product
Table 68. Illumina Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 69. Illumina Recent Development
Table 70. Thermo Fisher Company Details
Table 71. Thermo Fisher Business Overview
Table 72. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product
Table 73. Thermo Fisher Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 74. Thermo Fisher Recent Development
Table 75. Agilent Technologies Company Details
Table 76. Agilent Technologies Business Overview
Table 77. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product
Table 78. Agilent Technologies Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 79. Agilent Technologies Recent Development
Table 80. PerkinElmer Company Details
Table 81. PerkinElmer Business Overview
Table 82. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product
Table 83. PerkinElmer Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 84. PerkinElmer Recent Development
Table 85. Coopersurgical Company Details
Table 86. Coopersurgical Business Overview
Table 87. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product
Table 88. Coopersurgical Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 89. Coopersurgical Recent Development
Table 90. Abbott Laboratories Company Details
Table 91. Abbott Laboratories Business Overview
Table 92. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product
Table 93. Abbott Laboratories Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 94. Abbott Laboratories Recent Development
Table 95. Natera Company Details
Table 96. Natera Business Overview
Table 97. Natera Preimplantation Genetic Diagnosis (PGD) Product
Table 98. Natera Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 99. Natera Recent Development
Table 100. Takara Bio Company Details
Table 101. Takara Bio Business Overview
Table 102. Takara Bio Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 103. Takara Bio Recent Development
Table 104. Oxford Gene Technology Company Details
Table 105. Oxford Gene Technology Business Overview
Table 106. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product
Table 107. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 108. Oxford Gene Technology Recent Development
Table 109. Yikon Genomics Company Details
Table 110. Yikon Genomics Business Overview
Table 111. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product
Table 112. Yikon Genomics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 113. Yikon Genomics Recent Development
Table 114. Progenesis Company Details
Table 115. Progenesis Business Overview
Table 116. Progenesis Preimplantation Genetic Diagnosis (PGD) Product
Table 117. Progenesis Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 118. Progenesis Recent Development
Table 119. Beijing Genomics Institute Company Details
Table 120. Beijing Genomics Institute Business Overview
Table 121. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product
Table 122. Beijing Genomics Institute Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 123. Beijing Genomics Institute Recent Development
Table 124. Invitae Company Details
Table 125. Invitae Business Overview
Table 126. Invitae Preimplantation Genetic Diagnosis (PGD) Product
Table 127. Invitae Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 128. Invitae Recent Development
Table 129. Invicta Genetics Company Details
Table 130. Invicta Genetics Business Overview
Table 131. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product
Table 132. Invicta Genetics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 133. Invicta Genetics Recent Development
Table 134. Combimatrix Company Details
Table 135. Combimatrix Business Overview
Table 136. Combimatrix Preimplantation Genetic Diagnosis (PGD) Product
Table 137. Combimatrix Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 138. Combimatrix Recent Development
Table 139. Genea Limited Company Details
Table 140. Genea Limited Business Overview
Table 141. Genea Limited Preimplantation Genetic Diagnosis (PGD) Product
Table 142. Genea Limited Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 143. Genea Limited Recent Development
Table 144. Bioarray Company Details
Table 145. Bioarray Business Overview
Table 146. Bioarray Preimplantation Genetic Diagnosis (PGD) Product
Table 147. Bioarray Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 148. Bioarray Recent Development
Table 149. Quest Diagnostics Company Details
Table 150. Quest Diagnostics Business Overview
Table 151. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product
Table 152. Quest Diagnostics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 153. Quest Diagnostics Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Type: 2020 VS 2027
Figure 2. Chromosomal Abnormalities Features
Figure 3. Gender Selection Features
Figure 4. X-linked Diseases Features
Figure 5. Aneuploidy Features
Figure 6. Single Gene Disorders Features
Figure 7. Others Features
Figure 8. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2027
Figure 9. Maternity Centers & Fertility Clinics Case Studies
Figure 10. Hospitals, Diagnostic Labs, and Service Providers Case Studies
Figure 11. Research Laboratories & Academic Institutes Case Studies
Figure 12. Preimplantation Genetic Diagnosis (PGD) Report Years Considered
Figure 13. Global Preimplantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Preimplantation Genetic Diagnosis (PGD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Regions: 2020 VS 2027
Figure 16. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Regions (2022-2027)
Figure 17. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Players in 2020
Figure 18. Global Top Preimplantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnosis (PGD) as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnosis (PGD) Revenue in 2020
Figure 20. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
Figure 21. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2022-2027)
Figure 22. North America Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Preimplantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 24. North America Preimplantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 25. North America Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 26. United States Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Preimplantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 30. Europe Preimplantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 31. Europe Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 32. Germany Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Share by Region (2016-2027)
Figure 42. China Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Preimplantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 50. Latin America Preimplantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 51. Latin America Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 52. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 58. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Illumina Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 62. Thermo Fisher Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 63. Agilent Technologies Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 64. PerkinElmer Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 65. Coopersurgical Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 66. Abbott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 67. Natera Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 68. Takara Bio Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 69. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 70. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 71. Progenesis Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 72. Beijing Genomics Institute Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 73. Invitae Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 74. Invicta Genetics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 75. Combimatrix Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 76. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 77. Bioarray Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 78. Quest Diagnostics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の着床前遺伝子スクリーニング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preimplantation Genetic Screening Market The global Preimplantation Genetic Screening market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…- 世界の着床前遺伝子スクリーニング（PGS）技術市場規模・現状・予測（2021年-2027年） Preimplantation genetic screening (PGS) determines the chromosomal status of an embryo by screening all 23 chromosome pairs prior to transfer in an IVF cycle. Market Analysis and Insights: Global Preimplantation Genetic Screening (PGS) Technology Market The global Preimplantation Genetic Screening (…
- 世界の着床前遺伝子診断（PGD）市場規模・現状・予測（2021年-2027年） Preimplantation genetic diagnosis (PGD) is a procedure used prior to implantation to help identify genetic defects within embryos. This serves to prevent certain geneticdiseases or disorders from being passed on to the child. Market Analysis and Insights: Global Preimplantation Genetic Diagnostics (…
- 着床前遺伝学診断（PGD）のグローバル市場調査 2019年 The global Preimplantation Genetics Diagnosis (PGD) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Preimplantation Genetics Diagnosis (PGD) volume and value at global level, regional level and comp…
- 着床前遺伝学診断（PGD）のグローバル市場調査 2019年 The global Preimplantation Genetics Diagnosis (PGD) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Preimplantation Genetics Diagnosis (PGD) volume and value at global level, regional level and comp…